BioForce Nanosciences (OTCMKTS:BFNH) Issues Earnings Results

BioForce Nanosciences (OTCMKTS:BFNH) issued its quarterly earnings results on Tuesday. The company reported ($0.01) EPS for the quarter, Zacks reports.

BioForce Nanosciences Stock Performance

OTCMKTS BFNH traded down $0.01 during trading hours on Tuesday, reaching $0.56. The stock had a trading volume of 3,490 shares, compared to its average volume of 2,040. BioForce Nanosciences has a 52-week low of $0.16 and a 52-week high of $2.07. The stock has a fifty day moving average of $0.57 and a 200 day moving average of $0.81. The stock has a market cap of $18.71 million, a P/E ratio of -55.80 and a beta of -0.89.

BioForce Nanosciences Company Profile

BioForce Nanosciences Holdings, Inc focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. The company offers private label products with distributors and manufacturing providers. It sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, mass merchandisers, and online at www.bioforceeclipse.com, as well as through social media and telemarketing channels.